A proteomic approach to tumour target identification using phage display, affinity purification and mass spectrometry.

Tumour-associated cell surface markers are potential targets for antibody-based therapies. We have obtained a panel of myeloid cell binding single chain variable fragments (scFv) by applying phage display selection on myeloid cell lines followed by a selection round on freshly isolated acute myeloid leukaemia (AML) blasts using flow cytometry. To identify the target antigens, the scFv were recloned and expressed in an IgG(1) format and tested for their ability to immunoprecipitate cell surface proteins. The IgGs that reacted with distinct cell membrane extractable proteins were used in large-scale affinity purification of the target antigen followed by mass-spectrometry-based identification. Well-characterised cell surface antigens, such as leukocyte antigen-related receptor protein tyrosine phosphatase (LAR PTP) and activated leukocyte adhesion molecule (ALCAM) in addition to several unknown proteins, like ATAD3A, were identified. These experiments demonstrate that phage antibody selection in combination with affinity chromatography and mass spectrometry can be exploited successfully to identify novel antibody target molecules on malignant cells.

[1]  T. Logtenberg,et al.  Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments. , 2000, Journal of immunological methods.

[2]  T. Logtenberg,et al.  Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions. , 1995, Journal of molecular biology.

[3]  D. Elder,et al.  Combinatorial antibodies against human malignant melanoma. , 1997, Hybridoma.

[4]  C. Cohen,et al.  Post‐translational and cell type‐specific regulation of CXCR4 expression by cytokines , 2003, European journal of immunology.

[5]  I. Leigh,et al.  Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  Xiaoqing Zhang,et al.  Cell Type-dependent Differences in Thyroid Peroxidase Cell Surface Expression* , 2000, The Journal of Biological Chemistry.

[7]  L. Terstappen,et al.  Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Greenman,et al.  Isolation of human colorectal tumour reactive antibodies using phage display technology. , 2000, International journal of oncology.

[9]  T. Logtenberg,et al.  A novel helper phage that improves phage display selection efficiency by preventing the amplification of phages without recombinant protein. , 2003, Nucleic acids research.

[10]  S. Ferrone,et al.  Limited diversity of human scFv fragments isolated by panning a synthetic phage-display scFv library with cultured human melanoma cells. , 1998, Journal of immunology.

[11]  H. Ziegler-Heitbrock,et al.  Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. , 1996, Immunology today.

[12]  Mitsutoshi Nakamura,et al.  Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas , 2003, British Journal of Cancer.

[13]  A. Garen,et al.  Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Atkinson,et al.  Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype , 1991, The Journal of experimental medicine.

[15]  P. Carter,et al.  Identification of a human anti-CD55 single-chain Fv by subtractive panning of a phage library using tumor and nontumor cell lines. , 1999, Cancer research.

[16]  S. Barratt-Boyes.  Making the most of mucin: a novel target for tumor immunotherapy , 1996, Cancer Immunology, Immunotherapy.

[17]  O. Pourquié,et al.  The characterization, molecular cloning, and expression of a novel hematopoietic cell antigen from CD34+ human bone marrow cells. , 1997, Blood.

[18]  Identification of colon tumour-associated antigens by phage antibody selections on primary colorectal carcinoma. , 2001, European journal of cancer.

[19]  V. Quaranta,et al.  De novo identification of tumor-specific internalizing human antibody-receptor pairs by phage-display methods. , 2003, Journal of immunological methods.

[20]  Y. van Kooyk,et al.  MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule). , 1998, The American journal of pathology.

[21]  Tao Yang,et al.  Leukocyte common antigen–related tyrosine phosphatase receptor: Increased expression and neuronal‐type splicing in breast cancer cells and tissue , 1999, Molecular carcinogenesis.